Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Barchart

It Looks Like It’s Too Late to Buy This Little-Known Stock Up 180% Since Dec. 8

Troops (TROO) has surged 179% since a Trend Seeker “Buy” signal was issued on Dec. 8. Shares are up nearly 140% over the past 52 weeks. Despite the run-up, Morningstar estimates that TROO remains 44% undervalued with a $7.80 fair value. However, given low volume and the recent price spike,...

Barchart

This AI Data Center Power Stock is About to Break Out. Spot the Trade as It Unfolds With This Chart Signal.

Our top chart expert explains the TTM Squeeze setting up on Vistra’s chart, and what traders should be watching now.

Barchart

This Covered-Call Google ETF Yields 41%. These 2 Option Trades Are Even Better.

Self-directed investors are flocking to covered-call ETF strategies, but they are forgetting that there is a wide range of possible outcomes in the market.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

This Dividend Stock Gained 66% Last Year. Is The 2026 Forecast as Bright?

Citigroup shares gained almost 65% last year and outperformed large-cap banking peers. However, after the rally, Citi's dividend yield is now comparable to peers, and the valuations look fair, making the risk-reward quite balanced.

Barchart

Grain Market Update: The Outside Forces Moving Corn, Wheat, and Soybeans Now

Darin Newsom analyzes how seasonal demand and technical short-covering are fueling a temporary rally in corn, wheat, and soybeans, while warning that weak long-term fundamentals and shifting geopolitical landscapes in Venezuela and China suggest producers should use these price bounces to lock in future sales.

Barchart

Can This Healthcare Stock Keep Going After a Nearly 70% Surge?

Amneal Pharmaceuticals (AMRX) is trading at new 5-year highs with strong technical momentum. AMRX has gained 69% over the past year. Shares maintain a 100% “Buy” technical opinion on Barchart. Analyst sentiment is positive, with multiple “Strong Buy” ratings and price targets as high as $15. Today’s Featured Stock Valued...

Barchart

Unusual Volume in Marvell Technology Put Options - Is MRVL Stock Undervalued?

Today, unusual volume in out-of-the-money Marvell Technology put options is focusing attention on MRVL stock. Based on its recent acquisition and strong free cash flow, MRVL stock could be 38% undervalued.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Dear Oklo Stock Fans, Mark Your Calendars for January 7

Oklo shares push higher in anticipation of a key congressional hearing on nuclear energy on Jan. 7. But does that warrant buying OKLO stock at current levels?

Barchart

'Robots & Rockets Aren’t Made from Hopes & Wishes,' and How the AI Revolution is Shaping the Next Metals Bull Market

Our senior market strategist and longtime commodities analyst John Rowland, CMT, explains the secular bull market forming in industrial metals.

Barchart

Precious Metals Remain Strong: Why That’s a Red Flag for Stocks Amid Venezuela Tumult

It looks like precious metals traders may be the proverbial smartest people in the room as safe-haven demand for gold and silver remains strong.

Barchart

What's Driving the Parabolic Rise in Silver Futures, and How Long Can the Rally Last?

Amid rising geopolitical uncertainty, an exodus from fiat currencies, and surging demand from industries, silver keeps screaming higher. Here are the signals traders should watch.

Barchart

Newmont Mining Breaks Into the Top 100: A Bet on Venezuela’s Comeback?

Much has been made about Venezuela’s oil and natural gas revival after the capture of the country’s leader, Nicolas Maduro. However, the country’s vast mineral resources could be what gets Newmont Mining further into Latin America.

Barchart

Dell Technologies (DELL) Stock Options Could Be Unusually Mispriced

A combination of a necessary Wall Street anachronism and potential reflexivity may open doors for DELL stock.

Barchart

Nasdaq Stock Keeps Rising - Is It Worth Buying NDAQ Now?

Nasdaq stock is up over 16.4% in the last two months, and up +2.6% this year. So, is it worth buying NDAQ now? It's near analysts' price targets who may be waiting for upcoming results. One attractive play is selling short out-of-the-money puts.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Wall Street Is Split on This High-Yield Dividend Stock

Vodafone (VOD) is trading at a new 3-year high and has strong technical momentum. Shares are up nearly 61% over the past 52 weeks. VOD maintains a 100% “Buy” technical rating from Barchart. Some analysts warn that after its runup, Vodafone is now overvalued. Be cautious chasing this rally. Today’s...

Barchart

Halliburton Stock Just Pushed into Overbought Territory Amid Venezuela Tumult. Is There Still Time to Buy HAL?

Halliburton stock rallies as the U.S. launches a military operation in Venezuela. Here’s what could drive HAL shares higher in 2026.

Barchart

Cattle Bulls Are Hitting the Gas in 2026: What to Watch, and Why Grains and Hogs Are Down

Traders will be watching U.S.-China trade relations, a Russia-Ukraine peace deal, and new cases of the new world screwworm, among other catalysts as the new year kicks off.

Barchart

Why the Mexican Peso Could Keep Crushing the U.S. Dollar in 2026

The Mexican Peso crushed it in 2025 – up over 20% vs the USD! Higher rates in Mexico, a nearshoring boom from U.S. and Canadian companies, and a softer dollar made it happen. Peso is heading into 2026 strong!

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Analysts Love Salesforce Stock and Are Raising Their Price Targets - How to Play CRM

Analysts have been raising their price targets on Salesforce stock. This is despite CRM stock having been flat over the last month. One of the best plays here is to sell short out-of-the-money puts for income.

Barchart

An Alzheimer’s Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here?

vTv Therapeutics (VTVT) is a $156 million biopharma focused on small molecule drugs for Alzheimer’s, diabetes, and inflammatory disorders, all in clinical trials. VTVT has surged 182% over the past year, hitting a two-year high, with strong technical momentum. Wall Street leans “Strong Buy” with targets up to $47, but...

Barchart

Tesla Stock Has Been Flat For 2 Months - How to Make a 3.2% Yield in One-Month Puts

Tesla stock has been flat over the last 2 months. But investors are making money by selling short out-of-the-money (OTM) put options. For example, over the next month, a 6% OTM put provides a 3.2% income yield.

Barchart

3 Best Dividend Aristocrats to Buy in 2026

These Dividend Aristocrats have strong earnings growth, solid yields, and Wall Street buy ratings stand out as smart income plays for 2026.

Barchart

AppLovin Stock Just Plunged Below a Key Support Level. Should You Buy the Dip?

AppLovin shares lost another 8% in the first trading session of 2026, but fundamentals suggest APP stock is worth owning on the pullback.

Barchart

Unusual Options Activity: Revisiting The Best and Worst Bets From Q4 2025

I look back on the unusual options activity in Q4 2025, highlighting my best and worst bets. One thing I learned about options during the fourth quarter is that sometimes you can be overly clever with your strategy. Don’t be.

Barchart

Slow and Steady Wins the Race for This Insurance Stock

Chubb (CB) is trading at new 20-year highs and has strong technical momentum. Shares are up 13% over the past year, making it a slow-and-steady insurance stock. CB maintains a 100% technical “Buy” opinion from Barchart. Analysts and individual investors are largely bullish on the stock with price targets as...

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.